THE WOODLANDS, Texas (PRWEB) August 06, 2020. VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has closed on the purchase of greenfield for a new, expanded manufacturing facility. The site is located in Deison Technology Park in Conroe, TX and includes over 21 acres in the initial acquisition, with an option to purchase an additional 21 acres for future expansion. In collaboration with design-build partner BE&K, the Design Development phase of the project is well underway with groundbreaking planned in 3Q 2020 and substantial completion targeted by 3Q 2021. The first phase of the facility is expected to be operational by January 2022.
from Community Impact Houston
click here to view source
Leave a Reply